This is “Hot Topics” news related category.

An Update on the Burn Pits Accountability Act of 2019

2019-07-17T14:08:59+00:00July 17th, 2019|Hot Topics, News|

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted for, in order to call for further research focused on these veterans. Since the Persian Gulf War, a common waste disposal practice at military sites outside the United States was [...]

Lung Cancer News from the Largest Oncology Meeting

2019-07-15T19:43:44+00:00July 15th, 2019|Hot Topics, News|

Don't miss our next Lung Cancer Living Room! Join us Tuesday, July 16 at 5:30 pm (PT) to discuss the best of ASCO 2019 with Dr. Jacob Sands of Dana-Farber Cancer Institute. Watch on Facebook Live, YouTube, or the Living Room Library.  The GO2 Science and Research team just returned from the 2019 American Society of Clinical Oncology (ASCO) meeting. We connect you and your loved ones to the latest research and treatment options by keeping up with [...]

Make an Impact from Home, 7/23!

2019-07-11T14:43:08+00:00July 11th, 2019|Events, Hot Topics|

On July 23, over 130 advocates will meet with elected officials on Capitol Hill to advocate for the lung cancer community at the GO2 Foundation National Advocacy Summit. Now you have the opportunity to strengthen the collective voice and ignite change—without leaving your home! Join us on July 23 for Virtual Advocacy Action Day, an opportunity for you to echo the voices of advocates in Washington from wherever you are. We’ve made getting involved easy with pre-written tweets and emails, [...]

Lung Cancer Stigma’s Harmful Consequences

2019-07-10T17:27:28+00:00July 10th, 2019|Hot Topics|

Despite increased awareness around lung cancer in recent years, the stigma associated with the disease remains an issue for the lung cancer community. Beyond the known psychosocial issues associated with this stigma, our research has revealed that both patients and oncologists feel that the stigma can actually affect the level of care a patient receives and lead to worse health outcomes. Our very own Jennifer King, PhD, Senior Director, Science & Research, sat down with Cure magazine to discuss this social [...]

Going the Extra Mile: Jason’s Story

2019-06-27T21:03:20+00:00June 27th, 2019|Events, Hot Topics|

Losing a loved one to lung cancer is a pain that no one should have to experience. After Jason’s mother passed away from lung cancer in May 2018, he committed to doing something positive in her honor. On November 3, he’ll be running in the 2019 New York City Marathon as part of the GO2 Foundation Endurance Team; a group of committed athletes with a common goal of raising funds and awareness for lung cancer. In exchange for his entry to [...]

Patient Needs Represented on The Hill

2019-06-27T20:05:55+00:00June 27th, 2019|Hot Topics|

This week, The Hill hosted an event on Cost, Quality and Care: The Medicare Equation, where experts gathered to discuss the balancing act between Medicare affordability and quality of care. Our Co-founder, President, and CEO, Laurie Fenton Ambrose, brought the patient voice to the discussion. “Just addressing the cost of drugs is not going to necessarily fix the problem. We have to look at how we adapt resources to benefit the people who will be receiving them.” –Laurie Fenton Ambrose [...]

New Treatment Approved for Metastatic Small Cell Lung Cancer

2019-06-18T21:13:13+00:00June 18th, 2019|Hot Topics, News|

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for non-small cell lung cancer, this is the first approval of pembrolizumab for small cell lung cancer. This approval was based on two clinical trials, KEYNOTE-158 and KEYNOTE-028, which measured tumor [...]

Early Screening Equals Early Diagnosis

2019-06-18T16:14:25+00:00June 18th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening can take place in a community setting. Figure B: Percentage of each stage and type of lung cancer diagnosed at nonacademic centers compared with academic centers. Published in [...]

The Impact of One Advocate

2019-06-06T17:04:00+00:00June 6th, 2019|Hot Topics|

A cancer diagnosis can be difficult to grasp, but many caregivers and survivors find hope and strength through others who have walked a similar path. Lorraine Kerz, a past National Advocacy Summit attendee graciously agreed to be interviewed by us. We selected Lorraine because she is part of Merck’s “With Love, Me” campaign where she shares a heartfelt letter about her experience as the caregiver for her son, Silas. After losing Silas to lung cancer at the age of 29, [...]